Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Inversago Pharma - Series C round, October 2022
Inversago Pharma raised a Series C round for 68,740,000 USD in October, 2022.
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 18 Oct, 2022
Pavel Sorokin
edited on 18 Oct, 2022
Edits made to:
Infobox
(
+13
properties)
Infobox
Announcement URL
https://www.finsmes.com/2022/10/inversago-pharma-raises-cad95m-in-series-c-financing.html
Date Announced
October 17, 2022
Funding Round Date
October 17, 2022
Funding Round Amount (USD)
68,740,000
Funding Type
Series C
Investment
Fonds de solidarité FTQ
NEA (New Enterprise Associates)
Forbion Capital Partners
Genesys Capital
Amgen Ventures
JDRF T1D Fund
AmorChem
adMare BioInnovations
"update inverses"
Golden AI
edited on 18 Oct, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Funded Company
Inversago Pharma
"Created via: Web app"
Pavel Sorokin
created this topic on 18 Oct, 2022
Edits made to:
Infobox
(
+1
properties)
Inversago Pharma - Series C round, October 2022
Infobox
Is a
Funding round
Find more entities like Inversago Pharma - Series C round, October 2022
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE